05/14/2024
4:16 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
2:57 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
9:11 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
9:54 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
4:58 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:40 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:45 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
05/02/2024
4:37 PM | BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
9:49 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
12:59 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
3:11 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:21 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
2:07 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
8:49 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/11/2024
8:54 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/09/2024
3:24 PM | BioMarin Pharmaceutical (Filer)
| Form ARS | |
04/09/2024
3:07 PM | BioMarin Pharmaceutical (Filer)
| Form DEF 14A | |
04/09/2024
3:09 PM | BioMarin Pharmaceutical (Filer)
| Form DEFA14A | |
03/20/2024
4:13 PM | BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:48 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:50 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:53 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:55 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:36 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:42 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:46 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:54 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:32 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
4:35 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
11:04 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
1:41 PM | BioMarin Pharmaceutical (Subject)
FUCHS HENRY J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
11:04 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024
4:10 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:12 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:14 PM | BioMarin Pharmaceutical (Issuer)
Guyer Charles Greg (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:16 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:18 PM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
4:05 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
9:35 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Breaking News: Elon Musk Invents New Type of A.I. (Shocking) (Ad) Could Elon's New Device be Bigger than the iPhone?
According to 30-year Silicon Valley and Wall Street veteran, Eric Fry…
This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… |
02/26/2024
12:34 PM | BioMarin Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/13/2024
12:21 PM | BioMarin Pharmaceutical (Subject)
DODGE & COX (Filed by)
| Form SC 13G/A | |
02/12/2024
4:20 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
2:24 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/09/2024
4:46 PM | BioMarin Pharmaceutical (Subject)
Capital Research Global Investors (Filed by)
| Form SC 13G | |
02/09/2024
9:36 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/08/2024
8:46 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
6:47 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:06 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/11/2024
1:40 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
9:09 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
10:48 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/28/2023
12:00 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:03 PM | BioMarin Pharmaceutical (Issuer)
Countouriotis Athena (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
12:11 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:13 PM | BioMarin Pharmaceutical (Issuer)
Enyedy Mark J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
12:15 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/28/2023
12:18 PM | BioMarin Pharmaceutical (Issuer)
Bodem Barbara W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:14 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
8:57 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
4:22 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
5:18 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2023
10:49 AM | BioMarin Pharmaceutical (Subject)
Davis George Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023
6:55 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
4:13 PM | BioMarin Pharmaceutical (Issuer)
Hardy Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
1:53 PM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/17/2023
2:57 PM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
9:27 AM | Ajer Jeffrey Robert (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2023
12:59 PM | BioMarin Pharmaceutical (Issuer)
FUCHS HENRY J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
12:35 PM | BioMarin Pharmaceutical (Subject)
FUCHS HENRY J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2023
6:05 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2023
6:08 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
12:30 PM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023
9:39 AM | BIENAIME JEAN JACQUES (Reporting)
BioMarin Pharmaceutical (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/02/2023
11:48 AM | BioMarin Pharmaceutical (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2023
3:05 PM | BioMarin Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2023
10:35 AM | BioMarin Pharmaceutical (Issuer)
Mueller Brian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:23 PM | Alles Mark J (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:24 PM | ANDERSON ELIZABETH M (Reporting)
BioMarin Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:24 PM | BioMarin Pharmaceutical (Issuer)
Dere Willard H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:25 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:26 PM | BioMarin Pharmaceutical (Issuer)
Ho Maykin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:26 PM | BioMarin Pharmaceutical (Issuer)
HOMBACH ROBERT J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:27 PM | BioMarin Pharmaceutical (Issuer)
LAWLIS V BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:27 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:28 PM | BioMarin Pharmaceutical (Issuer)
PYOTT DAVID E I (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
5:29 PM | BioMarin Pharmaceutical (Issuer)
Slamon Dennis (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
4:31 PM | BioMarin Pharmaceutical (Issuer)
Burkhart Erin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
4:19 PM | BioMarin Pharmaceutical (Issuer)
Davis George Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
5:14 PM | BioMarin Pharmaceutical (Issuer)
HERON ELAINE J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Millionaire Investor makes surprising election prediction (Ad) Millionaire Investor Makes Surprising Election Prediction
Louis Navellier says he knows who's going to win the election. And how they could send six specific AI stocks through the roof on their first day. Click here for the full story… |
05/17/2023
5:14 PM | BioMarin Pharmaceutical (Issuer)
MEIER RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
